Alan Yu
@alanyuneph.bsky.social
Nephrologist, physician-scientist. Director, Division of Nephrology, Jared Grantham Kidney Institute, University of Kansas. Opinions are my own. #NephSky
Reposted by Alan Yu
Join us in congratulating this winner of the Distinguished Leader Award, an ASN Midcareer Award: Reem A. Mustafa, MD PhD MPH FASN. Read more about her work in #ASNKidneyNews: kidney.pub/KN1710-41
November 12, 2025 at 6:00 PM
Join us in congratulating this winner of the Distinguished Leader Award, an ASN Midcareer Award: Reem A. Mustafa, MD PhD MPH FASN. Read more about her work in #ASNKidneyNews: kidney.pub/KN1710-41
Reposted by Alan Yu
New podcast alert! Dr. Priya Vart discusses the results of his study, “Effects of Dapagliflozin on Health-Related Quality of Life in Patients with CKD,” with #ASNJASN Deputy Editor Manjula Kurella Tamura: kidney.pub/JPOD0776
November 13, 2025 at 4:00 PM
New podcast alert! Dr. Priya Vart discusses the results of his study, “Effects of Dapagliflozin on Health-Related Quality of Life in Patients with CKD,” with #ASNJASN Deputy Editor Manjula Kurella Tamura: kidney.pub/JPOD0776
Reposted by Alan Yu
And in the evening
- a CAR T in refractory SLE
- a PKD trial
- increasing PD in Vets
- Povetacicept in IgA
- TESTING Longterm term data
- what do the AHA/ACC BP guidelines mean?
#KidneyWk
- a CAR T in refractory SLE
- a PKD trial
- increasing PD in Vets
- Povetacicept in IgA
- TESTING Longterm term data
- what do the AHA/ACC BP guidelines mean?
#KidneyWk
November 8, 2025 at 2:11 PM
And in the evening
- a CAR T in refractory SLE
- a PKD trial
- increasing PD in Vets
- Povetacicept in IgA
- TESTING Longterm term data
- what do the AHA/ACC BP guidelines mean?
#KidneyWk
- a CAR T in refractory SLE
- a PKD trial
- increasing PD in Vets
- Povetacicept in IgA
- TESTING Longterm term data
- what do the AHA/ACC BP guidelines mean?
#KidneyWk
Reposted by Alan Yu
Starting Soon! Join us for the 2025 Best of ASN Journals session at #KidneyWk. Join us Tomorrow, Thursday, November 6 at 2:00 PM in Grand Ballroom A of the George R. Brown Convention Center for a lively discussion and check out the article collection below.
kidney.pub/BestOf2025
kidney.pub/BestOf2025
November 6, 2025 at 7:00 PM
Starting Soon! Join us for the 2025 Best of ASN Journals session at #KidneyWk. Join us Tomorrow, Thursday, November 6 at 2:00 PM in Grand Ballroom A of the George R. Brown Convention Center for a lively discussion and check out the article collection below.
kidney.pub/BestOf2025
kidney.pub/BestOf2025
Reposted by Alan Yu
The 2025 #ASNJASN #ASNCJASN and #ASNKidney360 Trainees of the Year are Benoit Brilland, Thomas Bais, and Yuhei Noda! This prize celebrates the best article submitted to each journal by a trainee as the first author.
See more about the contest and this year's winners: kidney.pub/TraineeOf...
See more about the contest and this year's winners: kidney.pub/TraineeOf...
November 6, 2025 at 8:00 PM
The 2025 #ASNJASN #ASNCJASN and #ASNKidney360 Trainees of the Year are Benoit Brilland, Thomas Bais, and Yuhei Noda! This prize celebrates the best article submitted to each journal by a trainee as the first author.
See more about the contest and this year's winners: kidney.pub/TraineeOf...
See more about the contest and this year's winners: kidney.pub/TraineeOf...
Reposted by Alan Yu
New in #ASNJASN: an epigenetic CRISPR Screen was used for the first time to identify critical genes and pathways involved in vascular calcification. kidney.pub/JASN0793
August 22, 2025 at 2:00 PM
New in #ASNJASN: an epigenetic CRISPR Screen was used for the first time to identify critical genes and pathways involved in vascular calcification. kidney.pub/JASN0793
Reposted by Alan Yu
NEW on the #AJKDBlog:
@maximalchange.bsky.social interviews the authors of a recent review of ADPKD, Sara S. Jdiaa and Reem A. Mustafa, and discusses prognosis, goals, and monitoring.
bit.ly/Jdiaa25 (FREE)
@maximalchange.bsky.social interviews the authors of a recent review of ADPKD, Sara S. Jdiaa and Reem A. Mustafa, and discusses prognosis, goals, and monitoring.
bit.ly/Jdiaa25 (FREE)
July 21, 2025 at 10:03 PM
NEW on the #AJKDBlog:
@maximalchange.bsky.social interviews the authors of a recent review of ADPKD, Sara S. Jdiaa and Reem A. Mustafa, and discusses prognosis, goals, and monitoring.
bit.ly/Jdiaa25 (FREE)
@maximalchange.bsky.social interviews the authors of a recent review of ADPKD, Sara S. Jdiaa and Reem A. Mustafa, and discusses prognosis, goals, and monitoring.
bit.ly/Jdiaa25 (FREE)
Reposted by Alan Yu
In a recent #ASNJASN article, authors report that ephrin-B1 at slit diaphragm suppresses cdc42 activity by preventing the interaction of Par6 with cdc42 and functions to keep the specialized phenotype of podocytes. Read more: kidney.pub/JASN0728 #BasicResearch
July 20, 2025 at 4:00 PM
In a recent #ASNJASN article, authors report that ephrin-B1 at slit diaphragm suppresses cdc42 activity by preventing the interaction of Par6 with cdc42 and functions to keep the specialized phenotype of podocytes. Read more: kidney.pub/JASN0728 #BasicResearch
Reposted by Alan Yu
Genetically modified gut bacteria show promise of combating kidney stones in clinical trial medicalxpress.com/news/2025-07...
Genetically modified gut bacteria show promise for combating kidney stones in clinical trial
The human gut microbiome has been shown to impact health in a myriad of ways. The type and abundance of different bacteria can impact everything from the immune system to the nervous system. Now, rese...
medicalxpress.com
July 18, 2025 at 9:49 PM
Genetically modified gut bacteria show promise of combating kidney stones in clinical trial medicalxpress.com/news/2025-07...
Reposted by Alan Yu
NEW on the #AJKDBlog:
@maximalchange.bsky.social interviews the authors of a recent review of ADPKD, Sara S. Jdiaa and Reem A. Mustafa, and discusses prognosis, goals, and monitoring.
bit.ly/Jdiaa25 (FREE)
@maximalchange.bsky.social interviews the authors of a recent review of ADPKD, Sara S. Jdiaa and Reem A. Mustafa, and discusses prognosis, goals, and monitoring.
bit.ly/Jdiaa25 (FREE)
July 19, 2025 at 4:02 PM
NEW on the #AJKDBlog:
@maximalchange.bsky.social interviews the authors of a recent review of ADPKD, Sara S. Jdiaa and Reem A. Mustafa, and discusses prognosis, goals, and monitoring.
bit.ly/Jdiaa25 (FREE)
@maximalchange.bsky.social interviews the authors of a recent review of ADPKD, Sara S. Jdiaa and Reem A. Mustafa, and discusses prognosis, goals, and monitoring.
bit.ly/Jdiaa25 (FREE)
Reposted by Alan Yu
⏳ One week left to apply. The Fellows’ Travel Support Scholarship gives nephrology fellows $1,000 to attend the UAB CRRT Academy. Train in person, build practical CRRT skills, and learn through simulation and expert-led sessions. Apply by Monday, July 21 👉 bit.ly/3FGntEx
July 14, 2025 at 9:02 PM
⏳ One week left to apply. The Fellows’ Travel Support Scholarship gives nephrology fellows $1,000 to attend the UAB CRRT Academy. Train in person, build practical CRRT skills, and learn through simulation and expert-led sessions. Apply by Monday, July 21 👉 bit.ly/3FGntEx
Reposted by Alan Yu
Guidelines no longer recommend holding typical first-line antihypertensive meds since renin will most often still be suppressed despite being on them in true PA. Growing evidence supports proceeding with screening
Hot off the press from the Endo Society: www.endocrine.org/clinical-pra...
Hot off the press from the Endo Society: www.endocrine.org/clinical-pra...
Primary Aldosteronism
A new Endocrine Society guideline on Primary Aldosteronism updates a 2016 guideline, and suggests that everyone who is diagnosed with hypertension have their levels of aldosterone, renin, and potassiu...
www.endocrine.org
July 15, 2025 at 4:35 PM
Guidelines no longer recommend holding typical first-line antihypertensive meds since renin will most often still be suppressed despite being on them in true PA. Growing evidence supports proceeding with screening
Hot off the press from the Endo Society: www.endocrine.org/clinical-pra...
Hot off the press from the Endo Society: www.endocrine.org/clinical-pra...
Reposted by Alan Yu
Could gene-targeted therapy be coming for autosomal dominant polycystic kidney disease? Farabursen, a new medication acquired by Novartis offers to potentially impact cyst formation and even regression. kidney.pub/KN1707-07 #ASNKidneyNews
@nephrosparks.bsky.social
@nephrosparks.bsky.social
July 16, 2025 at 4:00 PM
Could gene-targeted therapy be coming for autosomal dominant polycystic kidney disease? Farabursen, a new medication acquired by Novartis offers to potentially impact cyst formation and even regression. kidney.pub/KN1707-07 #ASNKidneyNews
@nephrosparks.bsky.social
@nephrosparks.bsky.social
Reposted by Alan Yu
𝗡𝗘𝗪 𝗥𝗘𝗦𝗢𝗨𝗥𝗖𝗘 𝗔𝗟𝗘𝗥𝗧: Download our #ADPKD infographic for a quick overview of diagnosis, delaying progression, complications & more. A handy resource for clinicians and patients alike!
⬇️https://www.theisn.org/wp-content/uploads/2025/07/ADPKD-Infographic.pdf
⬇️https://www.theisn.org/wp-content/uploads/2025/07/ADPKD-Infographic.pdf
July 7, 2025 at 4:23 PM
𝗡𝗘𝗪 𝗥𝗘𝗦𝗢𝗨𝗥𝗖𝗘 𝗔𝗟𝗘𝗥𝗧: Download our #ADPKD infographic for a quick overview of diagnosis, delaying progression, complications & more. A handy resource for clinicians and patients alike!
⬇️https://www.theisn.org/wp-content/uploads/2025/07/ADPKD-Infographic.pdf
⬇️https://www.theisn.org/wp-content/uploads/2025/07/ADPKD-Infographic.pdf
🔥Submit a Late-Breaking Clinical Trial and have your study considered for contemporaneous publication in JASN, NEJM @nejm.org or Lancet @thelancet.com
📣 The call for Late-Breaking Clinical Trials is open for ASN #KidneyWk 2025! Submit Phase 2, 3, or 4 clinical trials to present this November in Houston and reach 12,000+ kidney health professionals.
🗓️ Deadline: Tuesday, September 9, at 2:00 p.m. EDT
🔗 asn.kdny.info/Kbvo50WqwvO
🗓️ Deadline: Tuesday, September 9, at 2:00 p.m. EDT
🔗 asn.kdny.info/Kbvo50WqwvO
July 17, 2025 at 12:27 AM
🔥Submit a Late-Breaking Clinical Trial and have your study considered for contemporaneous publication in JASN, NEJM @nejm.org or Lancet @thelancet.com
Reposted by Alan Yu
Understanding the role of alternative splicing in podocyte biology may lead to theraputic options for patients with glomerular hypertension. Read more in a #BasicResearch article: kidney.pub/JASN0706 #ASNJASN
July 6, 2025 at 6:00 PM
Understanding the role of alternative splicing in podocyte biology may lead to theraputic options for patients with glomerular hypertension. Read more in a #BasicResearch article: kidney.pub/JASN0706 #ASNJASN
Reposted by Alan Yu
The 2026 RFAs for grant and fellowship awards from @pkdfoundation.bsky.social are out!
Grant: pkdcure.org/research/gra...
Fellowship: pkdcure.org/research/fel...
LOIs are due August 11. Send us your best ideas!!
Grant: pkdcure.org/research/gra...
Fellowship: pkdcure.org/research/fel...
LOIs are due August 11. Send us your best ideas!!
Grant Applications - Polycystic kidney disease | PKD treatment research | PKD Foundation
PKD Foundation Research RFA - With PKD Connect, no one will ever face polycystic kidney disease alone. Because patients, family and loved ones will always be connected to others who understand firstha...
pkdcure.org
July 2, 2025 at 5:43 PM
The 2026 RFAs for grant and fellowship awards from @pkdfoundation.bsky.social are out!
Grant: pkdcure.org/research/gra...
Fellowship: pkdcure.org/research/fel...
LOIs are due August 11. Send us your best ideas!!
Grant: pkdcure.org/research/gra...
Fellowship: pkdcure.org/research/fel...
LOIs are due August 11. Send us your best ideas!!
Reposted by Alan Yu
The June issue of JASN is now available online! Topics covered include:
- Blood Transfusion during Myocardial Infarction in CKD
- COL4A5 Variants in an Unselected Health System Population
- and more
Check out the issue: journals.lww.com/jas...
#ASNJASN
Cover by @ecorneclegall.bsky.social et al.
- Blood Transfusion during Myocardial Infarction in CKD
- COL4A5 Variants in an Unselected Health System Population
- and more
Check out the issue: journals.lww.com/jas...
#ASNJASN
Cover by @ecorneclegall.bsky.social et al.
June 2, 2025 at 5:00 PM
The June issue of JASN is now available online! Topics covered include:
- Blood Transfusion during Myocardial Infarction in CKD
- COL4A5 Variants in an Unselected Health System Population
- and more
Check out the issue: journals.lww.com/jas...
#ASNJASN
Cover by @ecorneclegall.bsky.social et al.
- Blood Transfusion during Myocardial Infarction in CKD
- COL4A5 Variants in an Unselected Health System Population
- and more
Check out the issue: journals.lww.com/jas...
#ASNJASN
Cover by @ecorneclegall.bsky.social et al.
Reposted by Alan Yu
Looks like the consolidation of NIDDK, NHLBI and NIAMS into “NI on Body Systems” proposed combined budget cut of 41%. #medsky #maha
No more NIDDK or NHLBI, combined into one institute
www.hhs.gov/sites/defaul...
h/t @jbrianbyrd.bsky.social
#MedSky
www.hhs.gov/sites/defaul...
h/t @jbrianbyrd.bsky.social
#MedSky
May 31, 2025 at 3:31 PM
Reposted by Alan Yu
New Podcast: Dr. Tobias Hermle & Dominik Spitz discuss a proof-of-concept for whole-animal drug screening using podocyte-like Drosophila nephrocytes. Pilot screen using the novel podocytopathy platform identifies that zacopride restores slit diaphragms despite excess of Rac1. https://bit.ly/JPOD0677
May 16, 2025 at 5:00 PM
New Podcast: Dr. Tobias Hermle & Dominik Spitz discuss a proof-of-concept for whole-animal drug screening using podocyte-like Drosophila nephrocytes. Pilot screen using the novel podocytopathy platform identifies that zacopride restores slit diaphragms despite excess of Rac1. https://bit.ly/JPOD0677
Reposted by Alan Yu
A powerful technique that directly edits proteins in living cells promises to help researchers to study proteins in improved ways.
https://go.nature.com/3GyiDJn
https://go.nature.com/3GyiDJn
Powerful protein editors offer new ways of probing living cells
Scientists deploy self-splicing protein subunits to insert strange new additions into target proteins.
go.nature.com
May 1, 2025 at 6:20 PM
A powerful technique that directly edits proteins in living cells promises to help researchers to study proteins in improved ways.
https://go.nature.com/3GyiDJn
https://go.nature.com/3GyiDJn
Reposted by Alan Yu
Coagulopathy: caused by nephrotic syndrome and worsening nephrotic syndrome!
Implications for future studies aiming at risk stratification for pro-thrombotic predisposition and treatment
#FSGS #sFSGS #nephroticsyndrome
Implications for future studies aiming at risk stratification for pro-thrombotic predisposition and treatment
#FSGS #sFSGS #nephroticsyndrome
Study shows plasma prothrombin levels modulated in vivo podocyte health and function in a rat model of glomerular disease. https://bit.ly/JASN0676
#ASNJASN
#BasicResearch
@drklotter.bsky.social
#ASNJASN
#BasicResearch
@drklotter.bsky.social
April 28, 2025 at 3:52 PM
Coagulopathy: caused by nephrotic syndrome and worsening nephrotic syndrome!
Implications for future studies aiming at risk stratification for pro-thrombotic predisposition and treatment
#FSGS #sFSGS #nephroticsyndrome
Implications for future studies aiming at risk stratification for pro-thrombotic predisposition and treatment
#FSGS #sFSGS #nephroticsyndrome
Reposted by Alan Yu
Study shows plasma prothrombin levels modulated in vivo podocyte health and function in a rat model of glomerular disease. https://bit.ly/JASN0676
#ASNJASN
#BasicResearch
@drklotter.bsky.social
#ASNJASN
#BasicResearch
@drklotter.bsky.social
April 27, 2025 at 7:00 PM
Study shows plasma prothrombin levels modulated in vivo podocyte health and function in a rat model of glomerular disease. https://bit.ly/JASN0676
#ASNJASN
#BasicResearch
@drklotter.bsky.social
#ASNJASN
#BasicResearch
@drklotter.bsky.social
Reposted by Alan Yu
📣 Don’t miss the review by @bolettalab.bsky.social & S. Clerici on metabolic and mitochondrial alterations in #PolycysticKidneyDisease and other renal #ciliopathies ➡️ doi.org/10.1038/s443...
at IRCCS San Raffaele Scientific Institute
at IRCCS San Raffaele Scientific Institute
April 22, 2025 at 2:49 PM
📣 Don’t miss the review by @bolettalab.bsky.social & S. Clerici on metabolic and mitochondrial alterations in #PolycysticKidneyDisease and other renal #ciliopathies ➡️ doi.org/10.1038/s443...
at IRCCS San Raffaele Scientific Institute
at IRCCS San Raffaele Scientific Institute